Immediate outcomes following the GLA:D® program in Denmark, Canada and Australia. A longitudinal analysis including 28, 370 patients with symptomatic knee or hip osteoarthritis. Issue 4 (April 2021)

• Record Type: Journal Article
• Authors: Roos, E.M.; Grønne, D.T.; Skou, S.T.; Zywiel, M.G.; McGlasson, R.; Barton, C.J.; Kemp, J.L.; Crossley, K.M.; Davis, A.M.
• Is Part Of: Osteoarthritis and cartilage. Volume 29:Issue 4(2021)
• Page Start: 502
• Page End: 506
• Publication Date: 2021-04
• Subjects: Exercise therapy -- Patient education -- Treatment -- Osteoarthritis -- Knee -- Hip; Osteoarthritis -- Periodicals; Cartilage -- Periodicals; Osteoarthritis -- Periodicals; Cartilage -- Periodicals; Arthrose -- Périodiques; Articulations -- Maladies -- Périodiques; 616.7223005
• DOI: 10.1016/j.joca.2020.12.024
• Languages: English
• ISSNs: 1063-4584

Abstract

Summary: Objective: To report outcomes across three countries for patients with symptomatic knee or hip OA attending the evidence-based education and exercise therapy program Good Life with osteoArthritis from Denmark (GLA:D®). Design: GLA:D® is a structured treatment program including 2–3 patient education sessions and 12 supervised exercise sessions delivered over 8 weeks by certified health care practitioners. The program was introduced in Denmark in 2013, in Canada 2015 and in Australia 2016. Absolute mean change in pain intensity, number of chair stands in 30 s, 40 m walk test time and Knee injury and Osteoarthritis Outcome Score (KOOS)/Hip dysfunction and Osteoarthritis Outcome Score (HOOS) QOL subscale scores from baseline to immediately after treatment were reported as means and 95 % CIs and proportion of responders for each country. Results: Patients from the three countries improved 26–33% in mean pain intensity, 8–12% in walking speed, 18–30% in chair stand ability and 12–26% in joint-related quality of life from baseline to immediately after treatment, with no clinically relevant differences between patients with hip and knee OA. These improvements correspond with moderate to large within-group effect sizes and 43–47 % of the patients experienced clinically relevant pain reductions. Conclusion: About half or more of patients across the three countries were categorized as responders for pain and objective function following the implementation of GLA:D®. These findings indicate positive patient outcomes associated with GLA:D® participation across varying health care systems from implementation of guideline-based patient education and exercise therapy for knee and hip OA.